Medicare Enrolled
Dr. Nanna Sulai, MD
Internal Medicine · Tyler, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sulai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sulai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sulai
Dr. Nanna Sulai is an internal medicine specialist in Tyler, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Sulai performed 86,311 Medicare services across 3,198 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sulai received a total of $3,656 from 38 pharmaceutical and/or device companies across 105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sulai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 1% volume in TX
$3,656 industry payments
Medicare Practice Summary
Medicare Utilization ↗86,311
Medicare services
Top 1% in TX for internal medicine
3,198
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,754 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 13,770 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 9,800 | $44 | $138 |
| Paclitaxel chemotherapy injection | 9,624 | $0 | $8 |
| Oxaliplatin chemotherapy injection | 9,120 | $0 | $33 |
| Darbepoetin injection (Aranesp) for anemia | 7,010 | $2 | $20 |
| Nivolumab injection (Opdivo) | 6,800 | $24 | $77 |
| Iron sucrose injection (Venofer) | 5,600 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 3,955 | $0 | $3 |
| Daratumumab injection (Darzalex) | 3,420 | $38 | $128 |
| Anti-nausea injection (fosaprepitant) | 2,550 | $0 | $5 |
| Immune globulin infusion (Octagam) | 2,520 | $34 | $236 |
| Dexamethasone injection (steroid) | 2,068 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 1,800 | $19 | $67 |
| Injection, granisetron hydrochloride, 100 mcg | 820 | $0 | $24 |
| Blood draw (venipuncture) | 598 | $8 | $20 |
| Comprehensive metabolic blood panel | 559 | $10 | $64 |
| Complete blood count (CBC) with differential | 552 | $8 | $36 |
| Office visit, established patient (30-39 min) | 527 | $92 | $368 |
| Injection of additional new drug or substance into vein | 509 | $12 | $108 |
| Injection, leucovorin calcium, per 50 mg | 427 | $3 | $25 |
| Anti-nausea injection (Aloxi/palonosetron) | 400 | $1 | $114 |
| Administration of chemotherapy into vein, 1 hour or less | 320 | $99 | $707 |
| Injection, carboplatin, 50 mg | 317 | $2 | $300 |
| Injection, fluorouracil, 500 mg | 308 | $2 | $13 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 275 | $272 | $2,762 |
| Injection, zoledronic acid, 1 mg | 220 | $6 | $431 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 180 | $74 | $1,348 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 144 | $48 | $313 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 135 | $3 | $373 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 129 | $22 | $157 |
| Injection, potassium chloride, per 2 meq | 128 | $0 | $1 |
| Injection, diphenhydramine hcl, up to 50 mg | 127 | $1 | $7 |
| Administration of additional new drug or substance into vein, 1 hour or less | 102 | $49 | $344 |
| Ferritin level test (iron stores) | 99 | $13 | $60 |
| Drug injection, under skin or into muscle | 97 | $11 | $96 |
| Iron level test | 92 | $6 | $27 |
| Iron binding capacity test | 91 | $9 | $35 |
| Administration of chemotherapy into vein, each additional hour | 88 | $21 | $161 |
| Injection, magnesium sulfate, per 500 mg | 88 | $1 | $6 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 73 | $55 | $211 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 64 | $360 | $1,722 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 61 | $178 | $700 |
| Unclassified drugs | 60 | $1 | $8 |
| New patient office visit, complex (60-74 min) | 55 | $149 | $709 |
| Infusion, normal saline solution , 1000 cc | 51 | $2 | $19 |
| Magnesium level test | 44 | $7 | $29 |
| Office visit, established patient, complex (40-54 min) | 41 | $131 | $496 |
| Ct scan of chest with contrast | 40 | $51 | $821 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 36 | $16 | $100 |
| Hospital follow-up visit, high complexity | 36 | $91 | $357 |
| Microscopic examination for white blood cells with manual cell count | 34 | $4 | $22 |
| Complete blood count (CBC), automated | 34 | $6 | $34 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 33 | $124 | $500 |
| Reticulated (young) platelet measurement | 29 | $35 | $143 |
| CT scan of abdomen and pelvis with contrast | 28 | $173 | $1,067 |
| Lactate dehydrogenase (enzyme) level | 28 | $6 | $31 |
| Irrigation of implanted venous access drug delivery device | 27 | $19 | $114 |
| Vitamin B-12 level test | 23 | $15 | $76 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 22 | $15 | $94 |
| Infusion into a vein for hydration, 31-60 minutes | 19 | $25 | $256 |
| Infusion into a vein for hydration, each additional hour | 19 | $10 | $75 |
| Administration of additional new drug or substance into vein using push technique | 17 | $42 | $289 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 16 | $26 | $145 |
| Application of on-body injector for under skin injection | 15 | $14 | $96 |
| Initial hospital admission, high complexity | 14 | $124 | $694 |
| Drawing of blood for a medical problem | 12 | $73 | $264 |
| Ct scan of abdomen and pelvis before and after contrast | 11 | $197 | $1,413 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
19.4% high complexity
76.7% medium
3.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,656
Total received (2021-2024)
Avg $914/year across 4 years
Top 21% in TX for internal medicine
38
Companies
105
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,166 (59.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,491 (40.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,813
2023
$632
2022
$198
2021
$13
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$1,509
AstraZeneca Pharmaceuticals LP
$249
ABBVIE INC.
$221
Tempus AI, Inc
$157
Amgen Inc.
$124
Regeneron Healthcare Solutions, Inc.
$102
Novartis Pharmaceuticals Corporation
$99
BeiGene USA, Inc.
$90
Lilly USA, LLC
$88
Incyte Corporation
$79
SOBI, INC
$79
Stemline Therapeutics Inc.
$79
Daiichi Sankyo Inc.
$75
GlaxoSmithKline, LLC.
$67
G1 Therapeutics, Inc.
$49
GENZYME CORPORATION
$44
PUMA BIOTECHNOLOGY, INC.
$42
Pharmacyclics LLC, An AbbVie Company
$42
Ipsen Biopharmaceuticals, Inc
$39
Astellas Pharma US Inc
$38
Boston Scientific Corporation
$33
Blueprint Medicines Corporation
$33
Genentech USA, Inc.
$29
Alexion Pharmaceuticals, Inc.
$27
Tactile Systems Technology Inc
$25
Seagen Inc.
$23
EMD Serono, Inc.
$22
JAZZ PHARMACEUTICALS INC.
$21
Mirati Therapeutics, Inc.
$20
CTI BioPharma Corp.
$20
Genmab U.S., Inc.
$19
Aveo Pharmaceuticals, Inc.
$19
E.R. Squibb & Sons, L.L.C.
$18
MorphoSys, US Inc.
$17
Sumitomo Pharma America, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$15
Janssen Biotech, Inc.
$14
Emmaus Medical, Inc.
$14
Top 3 companies account for 54.1% of total payments
Associated products mentioned in payments ›
AYVAKIT · BAVENCIO · BOSULIF · BRUKINSA · COSELA · Columvi · DOPTELET · Doptelet · ELZONRIS · ENHERTU · EPKINLY · Endari · Enhertu · Epkinly · FOTIVDA · Flexitouch Plus · IBRANCE · IMBRUVICA · IMFINZI · IMJUDO · JAKAFI · JEMPERLI · KISQALI · KRAZATI · LIBTAYO · Lunsumio · MONJUVI · NERLYNX · OJJAARA · ORGOVYX · Onivyde · Orserdu · Padcev · SARCLISA · SOMATULINE DEPOT · Stivarga · TABRECTA · TUKYSA · ULTOMIRIS · VERZENIO · VONJO · Vonjo · WATCHMAN Access System · XALKORI · XT CDX · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (59%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
170
Per 100K population
71.4
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sulai is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sulai experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Sulai performed 13,770 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sulai receive payments from pharmaceutical companies?
Yes. Dr. Sulai received a total of $3,656 from 38 companies across 105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sulai's costs compare to other internal medicine physicians in Tyler?
Dr. Sulai's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sulai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Tyler
Browse internal medicine physicians in Tyler ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology